Literature DB >> 4820637

Defective biliary excretion of copper in Wilson's disease.

D J Frommer.   

Abstract

The biliary excretion of copper was measured in eight patients with Wilson's disease (three untreated, with hepatic dysfunction) and 10 control subjects (three with hepatic dysfunction). The duodenum was perfused with an amino-acid solution containing a non-absorbed marker, (51)CrCl(3), and juice was aspirated from the duodeno-jejunal junction. The mean concentration of copper in the duodenal aspirate in Wilson's disease was significantly lower than in the control group. The mean biliary copper excretion rate in Wilson's disease of 8.6 +/- 0.8 mug/20 min (SEM) was also significantly below that of the control group (16.4 +/- 0.8 mug/20 min). The presence of liver dysfunction made no significant difference to the excretion rates in either group of patients. These results suggest that the copper accumulation in Wilson's disease is due to the inability of the liver to excrete copper into bile in adequate amounts.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4820637      PMCID: PMC1412902          DOI: 10.1136/gut.15.2.125

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  A fluorimetric and enzymatic method for the estimation of serum total bile acids.

Authors:  G M Murphy; B H Billing; D N Baron
Journal:  J Clin Pathol       Date:  1970-10       Impact factor: 3.411

2.  Some properties of an apoceruloplasmin-like protein in human serum.

Authors:  R J Carrico; H F Deutsch; H Beinert; W H Orme-Johnson
Journal:  J Biol Chem       Date:  1969-08-10       Impact factor: 5.157

3.  The absorption of biliary and non-biliary radiocopper in the rat.

Authors:  S P Mistilis; P A Farrer
Journal:  Scand J Gastroenterol       Date:  1968       Impact factor: 2.423

4.  Effect of jejunal amino acid perfusion and exogenous cholecystokinin on the exocrine pancreatic and biliary secretions in man.

Authors:  A Ertan; F P Brooks; J D Ostrow; D A Arvan; C N Williams; J J Cerda
Journal:  Gastroenterology       Date:  1971-11       Impact factor: 22.682

5.  Simultaneous measurements of total pancreatic, biliary, and gastric outputs in man using a perfusion technique.

Authors:  V L Go; A F Hofmann; W H Summerskill
Journal:  Gastroenterology       Date:  1970-03       Impact factor: 22.682

Review 6.  Copper metabolism.

Authors:  A Sass-Kortsak
Journal:  Adv Clin Chem       Date:  1965       Impact factor: 5.394

7.  Gastrointestinal absorption of copper: studies with 64Cu, 95Zr, a whole-body counter and the scintillation camera.

Authors:  P M Weber; S O'Reilly; M Pollycove; L Shipley
Journal:  J Nucl Med       Date:  1969-09       Impact factor: 10.057

8.  Metabolic studies in Wilson's disease. Evaluation of efficacy of chelation therapy in respect to copper balance.

Authors:  G T Strickland; R Q Blackwell; R H Watten
Journal:  Am J Med       Date:  1971-07       Impact factor: 4.965

9.  The binding of copper by bile and serum.

Authors:  D Frommer
Journal:  Clin Sci       Date:  1971-12       Impact factor: 6.124

10.  Metabolic balances of copper in patients with hepatolenticular degeneration submitted to vegetarian and mixed diets.

Authors:  H M Canelas; F B de Jorge; W A Tognola
Journal:  J Neurol Neurosurg Psychiatry       Date:  1967-08       Impact factor: 10.154

View more
  18 in total

1.  Wilson's Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

2.  [Insufficiency of the exocrine pancreas in Wilson's disease (author's transl)].

Authors:  P Osswald; K H Niessen
Journal:  Klin Wochenschr       Date:  1976-09-01

3.  Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease.

Authors:  Chun-Yan Wang; Jing-Wei Xie; Ye Xu; Tao Wang; Jian-Hui Cai; Xu Wang; Bao-Lu Zhao; Li An; Zhan-You Wang
Journal:  Antioxid Redox Signal       Date:  2013-05-03       Impact factor: 8.401

4.  Biliary copper excretion by hepatocyte lysosomes in the rat. Major excretory pathway in experimental copper overload.

Authors:  J B Gross; B M Myers; L J Kost; S M Kuntz; N F LaRusso
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

5.  Survey of copper granules in liver biopsy specimens from various liver abnormalities other than Wilson's disease and biliary diseases.

Authors:  H Miyamura; Y Nakanuma; N Kono
Journal:  Gastroenterol Jpn       Date:  1988-12

6.  Hudson memorial lecture: Wilson's disease: genetics and biochemistry--their relevance to therapy.

Authors:  J M Walshe
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

Review 7.  Copper in parenteral nutrition.

Authors:  M Shike
Journal:  Bull N Y Acad Med       Date:  1984-03

8.  Inherited copper toxicosis in Bedlington terriers: Wilson's disease (hepatolenticular degeneration).

Authors:  C A Owen; J Ludwig
Journal:  Am J Pathol       Date:  1982-03       Impact factor: 4.307

Review 9.  Practical recommendations and new therapies for Wilson's disease.

Authors:  G J Brewer
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

10.  Response of hepatic function to hepatic copper deposition in rats fed a diet containing copper.

Authors:  N Sugawara; D Li; C Sugawara; H Miyake
Journal:  Biol Trace Elem Res       Date:  1995 Aug-Sep       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.